148 related articles for article (PubMed ID: 9212988)
1. Application of long-circulating liposomes to cancer photodynamic therapy.
Oku N; Saito N; Namba Y; Tsukada H; Dolphin D; Okada S
Biol Pharm Bull; 1997 Jun; 20(6):670-3. PubMed ID: 9212988
[TBL] [Abstract][Full Text] [Related]
2. PEGylation of liposome decreases the susceptibility of liposomal drug in cancer photodynamic therapy.
Ichikawa K; Hikita T; Maeda N; Takeuchi Y; Namba Y; Oku N
Biol Pharm Bull; 2004 Mar; 27(3):443-4. PubMed ID: 14993821
[TBL] [Abstract][Full Text] [Related]
3. Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer.
Takeuchi Y; Kurohane K; Ichikawa K; Yonezawa S; Nango M; Oku N
Cancer; 2003 Apr; 97(8):2027-34. PubMed ID: 12673734
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic photodynamic therapy (PDT) by using long-circulating liposomes modified with peptide specific to angiogenic vessels.
Ichikawa K; Hikita T; Maeda N; Yonezawa S; Takeuchi Y; Asai T; Namba Y; Oku N
Biochim Biophys Acta; 2005 May; 1669(1):69-74. PubMed ID: 15843001
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy targeted to tumor-induced angiogenic vessels.
Kurohane K; Tominaga A; Sato K; North JR; Namba Y; Oku N
Cancer Lett; 2001 Jun; 167(1):49-56. PubMed ID: 11323098
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growth.
Ichikawa K; Takeuchi Y; Yonezawa S; Hikita T; Kurohane K; Namba Y; Oku N
Cancer Lett; 2004 Mar; 205(1):39-48. PubMed ID: 15036659
[TBL] [Abstract][Full Text] [Related]
7. Benzophenothiazine and benzoporphyrin derivative combination phototherapy effectively eradicates large murine sarcomas.
Cincotta L; Szeto D; Lampros E; Hasan T; Cincotta AH
Photochem Photobiol; 1996 Feb; 63(2):229-37. PubMed ID: 8657737
[TBL] [Abstract][Full Text] [Related]
8. Calculation of singlet oxygen dose using explicit and implicit dose metrics during benzoporphyrin derivative monoacid ring A (BPD-MA)-PDT in vitro and correlation with MLL cell survival.
Weston MA; Patterson MS
Photochem Photobiol; 2011; 87(5):1129-37. PubMed ID: 21575000
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of contact hypersensitivity with different analogs of benzoporphyrin derivative.
Simkin GO; King DE; Levy JG; Chan AH; Hunt DW
Immunopharmacology; 1997 Oct; 37(2-3):221-30. PubMed ID: 9403341
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative.
Young LH; Howard MA; Hu LK; Kim RY; Gragoudas ES
Arch Ophthalmol; 1996 Feb; 114(2):186-92. PubMed ID: 8573023
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic photodynamic therapy with targeted liposomes.
Oku N; Ishii T
Methods Enzymol; 2009; 465():313-30. PubMed ID: 19913174
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antitumor effects of BPD-MA-mediated photodynamic therapy combined with adriamycin on breast cancer in mice.
Tong ZS; Miao PT; Liu TT; Jia YS; Liu XD
Acta Pharmacol Sin; 2012 Oct; 33(10):1319-24. PubMed ID: 22842729
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of 5'-O-dipalmitoylphosphatidyl 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine is enhanced by long-circulating liposomalization.
Asai T; Kurohane K; Shuto S; Awano H; Matsuda A; Tsukada H; Namba Y; Okada S; Oku N
Biol Pharm Bull; 1998 Jul; 21(7):766-71. PubMed ID: 9703265
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of antivascular photodynamic therapy using benzoporphyrin derivative monoacid ring A (BPD-MA) in 14 dogs with oral and nasal tumors.
Osaki T; Takagi S; Hoshino Y; Okumura M; Kadosawa T; Fujinaga T
J Vet Med Sci; 2009 Feb; 71(2):125-32. PubMed ID: 19262021
[TBL] [Abstract][Full Text] [Related]
15. Intracellular target for photosensitization in cancer antiangiogenic photodynamic therapy mediated by polycation liposome.
Takeuchi Y; Ichikawa K; Yonezawa S; Kurohane K; Koishi T; Nango M; Namba Y; Oku N
J Control Release; 2004 Jun; 97(2):231-40. PubMed ID: 15196750
[TBL] [Abstract][Full Text] [Related]
16. Dextran-Benzoporphyrin Derivative (BPD) Coated Superparamagnetic Iron Oxide Nanoparticle (SPION) Micelles for T
Yan L; Luo L; Amirshaghaghi A; Miller J; Meng C; You T; Busch TM; Tsourkas A; Cheng Z
Bioconjug Chem; 2019 Nov; 30(11):2974-2981. PubMed ID: 31661959
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy for experimental tumors using ATX-S10(Na), a hydrophilic chlorin photosensitizer, and diode laser.
Mori M; Sakata I; Hirano T; Obana A; Nakajima S; Hikida M; Kumagai T
Jpn J Cancer Res; 2000 Jul; 91(7):753-9. PubMed ID: 10920284
[TBL] [Abstract][Full Text] [Related]
18. Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD).
Fingar VH; Kik PK; Haydon PS; Cerrito PB; Tseng M; Abang E; Wieman TJ
Br J Cancer; 1999 Apr; 79(11-12):1702-8. PubMed ID: 10206280
[TBL] [Abstract][Full Text] [Related]
19. Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin).
Akens MK; Hardisty MR; Wilson BC; Schwock J; Whyne CM; Burch S; Yee AJ
Breast Cancer Res Treat; 2010 Jan; 119(2):325-33. PubMed ID: 19263216
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic alteration of the surface receptor expression pattern of murine splenic dendritic cells.
King DE; Jiang H; Simkin GO; Obochi MO; Levy JG; Hunt DW
Scand J Immunol; 1999 Feb; 49(2):184-92. PubMed ID: 10075023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
